Drugs.com
JULY 14, 2024
SUNDAY, July 14, 2024 — Roughly 20% of Americans are diagnosed with skin cancer at some point in their lives, but it's not inevitable.Skin cancer is not only the most common cancer, it's also the most preventable. Most of the time, too much sun e.
Codon
JULY 14, 2024
Dr. Keith Neeves gives a history of blood transfusions and explains why it will be difficult to scale up the creation of synthetic blood for Issue 03 of Asimov Press. We are mostly blood. Of the 36 trillion cells in the human body, 32 trillion are blood cells. These blood cells synchronize the delivery of oxygen to every tissue in your body, fight pathogens, and heal wounds.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Patent Watch
JULY 14, 2024
This chart shows the drugs with the most patents in Austria. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.
Broad Institute
JULY 14, 2024
LatinX@Broad Presents The René Salazar Speaker Series: Mariana Matus By Rose Circeo July 14, 2024 Breadcrumb Home LatinX@Broad Presents The René Salazar Speaker Series: Mariana Matus Dr. Mariana Matus My Journey of spinning off my PhD research into a startup Learn more about the LatinX@Broad speaker series.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Drug Patent Watch
JULY 14, 2024
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Perficient: Drug Development
JULY 14, 2024
Welcome to the second installment of our Universal Design and Health Systems blog series. Today, we will delve into why Universal Design is essential for fostering inclusivity and accessibility in health systems. As healthcare systems evolve, ensuring that facilities, services, and technologies are accessible to all individuals, regardless of their abilities, is crucial.
Perficient: Drug Development
JULY 14, 2024
Welcome to the third installment of our Universal Design and Health System blog series. In this edition, we explore why Universal Design is crucial for enhancing patient experience within healthcare environments. Universal Design principles aim to create spaces and services that are accessible, inclusive, and user-friendly for all individuals, regardless of their abilities or disabilities.
Expert insights. Personalized for you.
259 
Let's personalize your content